Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 232

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 232
---
 to the January 2024 Warrants included in the units. The January 2024 Pre-Funded Warrants have an exercise price of $ 0.60per share, were immediately exercisable beginning on January 31, 2024 until exercised in full. The January 2024 Warrants have an exercise price of $ 25.41per share and are exercisable beginning on January 31, 2024 until January 31, 2029. The Company granted WallachBeth Capital LLC a 45-day over-allotment option to purchase up to 13,153shares of the Company’s common stock at a price of $ 23.10per share and/or 15,650January 2024 Warrants at a price of $ 0.60per warrant and/or 2,498January 2024 Pre-Funded Warrants at a price of $ 22.50per pre-funded warrant, or any combination thereof, in all cases less the underwriting discount. WallachBeth Capital LLC partially exercised its over-allotment option with respect to 13,637January 2024 Warrants on January 31, 2024, and purchased an additional oneshare of common stock at a purchase price of $ 22.50per share and oneJanuary 2024 Warrant at a purchase price of $ 0.60per warrant on February 14, 2024. The Company also issued to WallachBeth Capital LLC warrants (the “January 2024 Representative Warrants”) to purchase 6,260shares of the Company’s common stock at an exercise price of $ 25.41per share. The January 2024 Representative Warrants are exercisable beginning on January 31, 2024 until January 31, 2029. The units and pre-funded units were offered and sold pursuant to the Company’s Registration Statement on Form S-1 (File No. 333-276641), declared effective by the SEC on January 29, 2024. The closing of the January 2024 Offering occurred on January 31, 2024, generating net proceeds to the Company of approximately $ 1.9million, after deducting underwriting discounts and commissions and the payment of other offering expenses payable by the Company of approximately $ 510,000. On February 1, 2024 and April 9, 2024, the Company issued 8,326shares and 8,326shares of common stock, respectively upon the